-+ 0.00%
-+ 0.00%
-+ 0.00%

Omnicell publishes investor presentation on autonomous pharmacy, OmniSphere platform and Titan XT system

PUBT·04/28/2026 10:49:11
Listen to the news
Omnicell publishes investor presentation on autonomous pharmacy, OmniSphere platform and Titan XT system
  • Omnicell outlined strategy to advance autonomous medication management across points of care, central pharmacy, IV room, specialty pharmacy, ambulatory care.
  • Company highlighted installed base spanning more than half of top 300 US health systems.
  • Omnicell positioned Titan XT automated dispensing system, powered by cloud-native OmniSphere platform, as next-generation product aimed at streamlining pharmacy workflows, strengthening nursing safeguards, simplifying IT operations.
  • Management targeted expansion of SaaS and expert services to lift recurring revenue, projected at 22% of total revenue in FY 2026.
  • Omnicell reported product backlog of $640 million as of 12/31/2025; annual recurring revenue of $636 million as of 12/31/2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Omnicell Inc. published the original content used to generate this news brief on April 28, 2026, and is solely responsible for the information contained therein.